3B2W
Crystal structure of pyrimidine amide 11 bound to Lck
3B2W の概要
| エントリーDOI | 10.2210/pdb3b2w/pdb |
| 関連するPDBエントリー | 2OFV |
| 分子名称 | Proto-oncogene tyrosine-protein kinase LCK, N-[5-({[2-fluoro-3-(trifluoromethyl)phenyl]amino}carbonyl)-2-methylphenyl]-4-methoxy-2-[(4-piperazin-1-ylphenyl)amino]pyrimidine-5-carboxamide (3 entities in total) |
| 機能のキーワード | lck, kinase domain, alternative splicing, atp-binding, chromosomal rearrangement, cytoplasm, disease mutation, host-virus interaction, lipoprotein, membrane, myristate, nucleotide-binding, palmitate, phosphorylation, proto-oncogene, sh2 domain, sh3 domain, transferase, tyrosine-protein kinase |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Cytoplasm: P06239 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 32682.26 |
| 構造登録者 | |
| 主引用文献 | Deak, H.L.,Newcomb, J.R.,Nunes, J.J.,Boucher, C.,Cheng, A.C.,DiMauro, E.F.,Epstein, L.F.,Gallant, P.,Hodous, B.L.,Huang, X.,Lee, J.H.,Patel, V.F.,Schneider, S.,Turci, S.M.,Zhu, X. N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR. Bioorg.Med.Chem.Lett., 18:1172-1176, 2008 Cited by PubMed Abstract: N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure-activity relationships, and the synthesis of these inhibitors are reported herein. PubMed: 18083554DOI: 10.1016/j.bmcl.2007.11.123 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






